Table 4.
C-index | P value | NRI | P value | IDI | P value | |
---|---|---|---|---|---|---|
Established risk factor model | 0.741 | Ref. | Ref. | Ref. | ||
Established risk factor model + NT-proBNP | 0.762 | 0.38 | 0.316 | <0.001 | 0.018 | <0.001 |
Established risk factor model + L-FABP | 0.794 | 0.03 | 0.561 | <0.001 | 0.092 | <0.001 |
Established risk factor model + NT-proBNP + L-FABP | 0.803 | 0.01 | 0.606 | <0.001 | 0.101 | <0.001 |
Established risk factor model + NT-proBNP + L-FABP vs | 0.041* | 0.08 | 0.513 | <0.001 | 0.083 | <0.001 |
Established risk factor model + NT-proBNP | ||||||
Established risk factor model + NT-proBNP + L-FABP vs | 0.009* | 0.70 | 0.256 | <0.001 | 0.009 | 0.006 |
Established risk factor model + L-FABP |
Established risk factors included age, sex, hypertension, dyslipidemia, diabetes mellitus, smoking status, chronic kidney disease, atrial fibrillation, acute decompensated heart failure, previous myocardial infarction, previous coronary revascularization, systolic blood pressure, heart rate, emergent coronary angiography or percutaneous coronary intervention before admission, mechanical ventilation before admission, intraaortic balloon pump before admission
L-FABP liver-type fatty acid-binding protein, NT-proBNP N-terminal pro-B-type natriuretic peptide, AKI acute kidney injury, NRI net reclassification improvement, IDI integrated discrimination improvement, Ref. reference
*Estimated differences between two groups